Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Bitcoin's recent drop not linked to SpaceX IPO demand, stablecoin data shows no mass crypto sell-off.

Market News
06 Jun 2026
Crypto news
View Source
Neutral
pluang ai news

Bitcoin's recent 16% price drop coincided with SpaceX's IPO marketing, sparking speculation that retail demand for the IPO caused crypto selling. However, data from CryptoQuant shows no unusual outflows of stablecoins like USDC or Tether, which would indicate a mass move to cash. Large withdrawals of Bitcoin and Ether from exchanges suggest buyers moved coins to private wallets rather than panic selling. The SpaceX IPO is expected to price on June 11 with heavy retail interest, but brokerage data is needed to fully confirm any crypto-to-IPO fund shifts. Meanwhile, Bitcoin ETFs have seen significant outflows, confirming some crypto selling pressure.

More News

Jyske Realkredit sets coupon rates for multiple bond series from July to September 2026.

Jyske Realkredit sets coupon rates for multiple bond series from July to September 2026.

Jyske Realkredit A/S announced fixed coupon rates for several bond series effective from July 1 to September 30, 2026. The rates range from 2.31% to 2.92% per annum depending on the bond series. This update informs investors about the expected return...

Company Fundamentals
Neutral
2 hours ago
Jyske Realkredit sets coupon interest rates for multiple bond series from July to September 2026.

Jyske Realkredit sets coupon interest rates for multiple bond series from July to September 2026.

Jyske Realkredit A/S announced the fixed coupon interest rates for several bond series effective from July 1, 2026, to September 30, 2026. The rates range from 2.31% to 2.92% per annum depending on the bond series. This update informs investors about...

Company Fundamentals
Neutral
2 hours ago
Nyrstar publishes legal opinion on effects of company liquidation amid ongoing criminal proceedings.

Nyrstar publishes legal opinion on effects of company liquidation amid ongoing criminal proceedings.

Nyrstar NV released a legal opinion addressing the impact of its potential dissolution and liquidation on ongoing criminal cases and its ability to pursue claims against responsible third parties. This follows a notice from the FSMA and aims to clari...

Market News
Neutral
2 hours ago
Nyrstar releases legal advice on company dissolution and ongoing criminal case implications

Nyrstar releases legal advice on company dissolution and ongoing criminal case implications

Nyrstar NV has published a legal opinion from external lawyers regarding the impact of a potential company dissolution and liquidation on an ongoing criminal procedure and the company's ability to protect its rights by possibly filing claims against ...

Market News
Neutral
2 hours ago
Oblenio Bio raises $62M to advance autoimmune drug LBL-051 into clinical trials.

Oblenio Bio raises $62M to advance autoimmune drug LBL-051 into clinical trials.

Oblenio Bio secured $62 million in a Series B funding round led by Pfizer Ventures to support clinical development of LBL-051, a tri-specific T-cell engager targeting autoimmune diseases. LBL-051 aims to reset the immune system by depleting B-cells a...

Company Fundamentals
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App